Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

Gynecologic Oncology

Volumn 145, Issue 3, 2017, Pages 519-525

  Creasman, William T ^a   Ali, Shamshad ^b   Mutch, David G ^c   Zaino, Richard J ^d   Powell, Matthew A ^c   Mannel, Robert S ^e   Backes, Floor J ^f   DiSilvestro, Paul A ^g   Argenta, Peter A ^h   Pearl, Michael L ⁱ   Lele, Shashikant B ^b   Guntupalli, Saketh R ^j   Waggoner, Steven ^k   Spirtos, Nick ^l   Boggess, John F ^m   Edwards, Robert P ⁿ   Filiaci, Virginia L ^b   Miller, David S ^o  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g WOMEN AND INFANTS HOSPITAL   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

ⁱ STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l Women's Cancer Center of Nevada   (United States)

^m UNIVERSITY OF NORTH CAROLINA   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

Poor histotypes; Surgical pathology

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CLINICAL PROTOCOL; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERUS CARCINOMA; CANCER GRADING; CARCINOMA, ENDOMETRIOID; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; ENDOMETRIAL NEOPLASMS; ETHNOLOGY; MIDDLE AGED; MULTICENTER STUDY; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CROSS-SECTIONAL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; UNITED STATES;

EID: 85017127669     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2017.03.017     Document Type: Article

References (8)

1. American Cancer Society, Cancer Facts & Figures 2015. 2015, American Cancer Society, Atlanta.
2. Creasman, W.T., Morrow, C.P., Bundy, B.N., Homesley, H.D., Graham, J.E., Heller, P.B., Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 (1987), 2035–2041.
3. The Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 474 (2011), 609–615.
4. Bokhman, J.V., Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15 (1983), 10–17.
5. Hamilton, C.A., Cheung, M.K., Osann, K., Chen, L., Teng, N.N., Longacre, T.A., et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancer. B J. Cancer 94 (2006), 642–646.
6. Setiawan, V.W., Yang, H.P., Pike, M.C., McCann, S.E., et al. Type I and II endometrial cancers: have they different risk factors?. J. Clin. Oncol. 31 (2013), 2607–2618.
7. Chan, J.K., Loizz, V., Youssef, M., Osann, K., Rutgers, J., Vasilev, S.A., et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol. Oncol. 90 (2003), 181–185.
8. Clement, P.B., Young, R., Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv. Anat. Pathol. 11 (2004), 117–142.